Givinostat
Commons · Question 23967 · Tabled 14 Jan 2025 · Department of Health and Social Care · Official record
Answered 20 Jan 2025
Question
Asked by Martin Wrigley
To ask the Secretary of State for Health and Social Care, if he will have discussions with NICE on the potential merits of offering Givinostat for Duchenne muscular dystrophy.
Answer
Answered by Karin Smyth, 20 Jan 2025
There are no plans to have discussions with the National Institute for Health and Care Excellence (NICE) on offering givinostat for Duchenne muscular dystrophy. The NICE makes recommendations for the National Health Service on whether new licensed medicin...